p38-MAPK

p38 mitogen-activated protein kinase (MAPK) inhibitors act on stress-activated kinases of the MAPK family. In 1994 p38 was described as a kinase phosphorylated on tyrosine after exposure of cells to bacterial endotoxin or hyperosmolarity. In the same year, a kinase targeted by pyridinyl imidazole compounds was shown to regulate the biosynthesis of inflammatory cytokines. Adezmapimod, also known as SB 203580, and SB 202190 belong to this pyridinyl imidazole class and inhibit p38α and p38β. Doramapimod binds an allosteric pocket that becomes accessible in an inactive conformation of the kinase, a binding mode reported in 2002. PH-797804 and ralimetinib dimesylate are further p38α inhibitors for studies of inflammatory and stress signaling.

8 Items

  • Bilobetin
    Cat. No.
    A15680

    Bilobetin

    Bilobetin acts as a PPARα activator, enhancing lipid metabolism and insulin sensitivity. It effectively reduces blood lipid levels by promoting hepatic lipid uptake and oxidation, while decreasing triglyceride secretion and accumulation in tissues. Additionally, Bilobetin stimulates the phosphorylation and nuclear translocation of PPARα, resulting in increased cAMP levels and PKA activity. This compound is significant for research in metabolic disorders, particularly those related to insulin resistance and lipid regulation.

    1 mg
    $30.00
    2 mg
    $50.00
    All 7 sizes
  • MTBT
    Cat. No.
    A30754

    MTBT

    MTBT is a p38 MAPK activator with notable anticancer properties. It effectively inhibits tumor cell proliferation, inducing cell cycle arrest and apoptosis. MTBT enhances the phosphorylation of histone H3 at serine residues in cancer cells, thereby facilitating cell cycle arrest in the M phase. The specific p38 MAPK inhibitor Adezmapimod can reverse the cell cycle arrest effects initiated by MTBT, making it a valuable tool in cancer research and therapeutic studies.

    5 mg
    $410.00
    10 mg
    $670.00
    All 5 sizes
  • Iroxanadine sulfate
    Cat. No.
    A37534

    Iroxanadine sulfate

    Synonyms: (-)-BRX 005 sulfate; (-)-BRX 235 sulfate

    Iroxanadine sulfate is a dual activator of p38 kinase and heat shock protein (HSP), functioning as a vasculoprotector. This compound exhibits significant biological activity relevant to vascular health and has potential applications in the study of atherosclerosis and other vascular diseases. Researchers may utilize Iroxanadine sulfate to explore therapeutic strategies aimed at modulating p38 and HSP signaling pathways in various models of vascular pathology.

    25 mg
    $1,655.00
    50 mg
    $2,115.00
    All 3 sizes
  • (±)-Iroxanadine
    Cat. No.
    A37628

    (±)-Iroxanadine (BRX 005, BRX 235)

    Synonyms: BRX 005; BRX 235

    (±)-Iroxanadine serves as a p38 kinase and heat shock protein (HSP) activator, demonstrating vasculoprotective properties. This compound is pertinent for research into atherosclerosis and various vascular diseases, facilitating studies aimed at understanding the molecular mechanisms underlying these conditions. Its activation of key signaling pathways makes it a valuable tool for exploring therapeutic targets in cardiovascular research.

    1 mg
    $115.00
    5 mg
    $285.00
    All 7 sizes
  • Iroxanadine hydrochloride
    Cat. No.
    A37632

    Iroxanadine hydrochloride

    Synonyms: (-)-BRX 005 hydrochloride; (-)-BRX 235 hydrochloride

    Iroxanadine hydrochloride is a dual activator of p38 mitogen-activated protein kinase (MAPK) and heat shock proteins (HSPs). It exhibits vasculoprotective properties, making it a valuable tool for investigating mechanisms underlying atherosclerosis and various vascular diseases. This reagent is suitable for research applications focused on the modulation of inflammatory responses and cellular stress pathways.

    Out of stock

    All 3 sizes
  • Iroxanadine hydrobromide
    Cat. No.
    A37639

    Iroxanadine hydrobromide

    Synonyms: (-)-BRX 005 hydrobromide; (-)-BRX 235 hydrobromide

    Iroxanadine hydrobromide is a potent activator of p38 MAPK and HSP proteins. This compounds biological activity focuses on vasculoprotection, making it a valuable tool for investigating atherosclerosis and other vascular diseases. Its dual activation mechanisms provide insights into cellular stress responses and inflammation, making it relevant for research applications in cardiovascular health.

    25 mg
    $1,905.00
    50 mg
    $2,445.00
    All 3 sizes
  • Iroxanadine
    Cat. No.
    A37640

    Iroxanadine

    Synonyms: (-)-BRX 005; (-)-BRX 235

    Iroxanadine is a dual activator of p38 MAPK and heat shock proteins (HSPs). It exhibits vasculoprotective properties, making it a valuable reagent for studying atherosclerosis and other vascular diseases. This compound can be utilized in research focusing on inflammatory responses and cardiovascular health, providing insights into the mechanisms underlying these conditions.

    Out of stock

    All 3 sizes
  • OVA-E1 peptide
    Cat. No.
    A40663

    OVA-E1 peptide

    OVA-E1 peptide is an activator of p38 MAPK, derived from the original SIINFEKL sequence (OVA 257-264). This peptide effectively stimulates both p38 and JNK signaling pathways in both mutant and wild-type thymocytes. It serves as a valuable tool for studying MAPK pathways and their roles in cellular responses such as inflammation and stress signaling in various research applications.

    Out of stock

    All 3 sizes

8 Items

Added to your cart

View Cart Checkout

    Loading...